New Key Statistics Module, Z-Score and F-Score
XSWX:MED Key Ratios
| Market Cap CHF M | 1,108.98 |
| Enterprise Value CHF M | 1,290.44 |
| P/E(ttm) | 74.25 |
| PE Ratio without NRI | 84.06 |
| Forward PE Ratio | 63.40 |
| Price/Book | 3.93 |
| Price/Sales | 3.62 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 29.11 |
| Payout Ratio % | -- |
| Revenue (TTM) CHF M | 307.00 |
| EPS (TTM) CHF | 1.20 |
| Beneish M-Score | -2.11 |
| 10-y EBITDA Growth Rate % | 9.40 |
| 5-y EBITDA Growth Rate % | 22.00 |
| y-y EBITDA Growth Rate % | 55.00 |
| EV-to-EBIT | 49.45 |
| EV-to-EBITDA | 23.46 |
| PEG | 3.82 |
| Shares Outstanding M | 12.45 |
| Net Margin (%) | 4.86 |
| Operating Margin % | 1.98 |
| Pre-tax Margin (%) | 7.38 |
| Quick Ratio | 1.72 |
| Current Ratio | 3.36 |
| ROA % (ttm) | 2.74 |
| ROE % (ttm) | 5.47 |
| ROIC % (ttm) | 0.93 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.15 |
XSWX:MED Number of Guru Trades
XSWX:MED Volume of Guru Trades
Gurus Latest Trades with XSWX:MED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XSWX:MED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data